GuideOncology
Diagnosis-specific GPA for brain metastases (DS-GPA)
Survival prognostic index for brain metastases with factors that differ by primary tumour.
Updated 3 November 2026
When to use it
At diagnosis of brain metastases, to estimate survival, guide treatment intensity and stratify trials.
What it is
The GPA (Graded Prognostic Assessment) was published in 2008 with 1,960 patients from RTOG trials and was as prognostic as RPA but simpler. Diagnosis-specific versions followed (DS-GPA, 2012) and updates with molecular markers, summarised in 2020 with 6,984 patients.
Keep reading in the app
- Factors considered
- How to interpret it
- Limitations
Practical tip
The score ranges from 0 (worst prognosis) to 4 (best) and the factors change by primary.
2 more practical tips in the app.
Reference
- Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510-514.
- Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012;30(4):419-425.
- Sperduto PW, Mesko S, Li J, et al. Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol. 2020;38(32):3773-3784.
Official source: Official GPA calculator (authors)
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
